CN104922512A - Medicine for treating herpes zoster - Google Patents
Medicine for treating herpes zoster Download PDFInfo
- Publication number
- CN104922512A CN104922512A CN201510306626.XA CN201510306626A CN104922512A CN 104922512 A CN104922512 A CN 104922512A CN 201510306626 A CN201510306626 A CN 201510306626A CN 104922512 A CN104922512 A CN 104922512A
- Authority
- CN
- China
- Prior art keywords
- parts
- heat
- medicine
- herpes zoster
- clears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to medicine for treating herpes zoster. The medicine is prepared from the following crude drugs in parts by weight: 15 parts of lalang grass rhizome, 9 parts of rhizoma atractylodis macrocephalae, 9 parts of radix paeoniae alba, 9 parts of mint, 10 parts of lemon peel, 6 parts of glossy privet fruit, 20 parts of lysimachia christinae hance, 12 parts of red-spotted stonecrop, 9 parts of radix sophorae flavescentis and 6 parts of melia azedarach flower. According to the medicine, lysimachia christinae hance clears the dampness-heat of liver and gallbladder; radix sophorae flavescentis and melia azedarach flower clears heat, dries dampness, kills parasites to relieve itching; radix paeoniae alba nourishes blood, relieves spasm, calms liver, and relieves pain; supplemented red-spotted stonecrop clears heat, and removes toxicity; lalang grass rhizome removes heat to cool blood; rhizoma atractylodis macrocephalae invigorates spleen, and supplements qi; mint promotes eruption, and relieves itching; lemon peel promotes qi circulation, and relieves pain; glossy privet fruit tonifiers liver and kidney, and clears deficient heat; if used together, all the crude drugs together play the efficacies of eliminating dampness and heat, clearing heat and removing toxicity, promoting qi circulation, and relieving pain.
Description
Technical field
The present invention relates to a kind of medicine, be specifically related to a kind of Chinese medicine being used for the treatment of herpes zoster.
Background technology
Herpes zoster is herpes zoster is a kind of common clinical, frequently-occurring disease, sharp ache, and durante dolors is very long, and what have even continues 2 ~ 3 years; Herpes zoster is the acute inflammation dermatoses caused by varicella zoster virus, its virus can be hidden for a long time in spinal cord posterior root ganglion, after the resistance of patient declines, virus meeting growth and breeding again, makes peripheral nerve involve skin and all herpes zoster may occur.Herpes zoster is worldwide pandemic, and according to statistics in Britain, in 3534 people, herpes zoster annual morbidity is 3.39%; The U.S. has 300,000 routine banded roe deer rash patients every year.The main complication of herpes zoster is postherpetic neuralgia, and herpes ophthalmicus can involve eyeball, panophthalmitis or facial paralysis occurs, encephalitis, even threat to life.Our Chinese medicine claims herpes zoster to be " herpes zoster " or " herpes zoster ", and Chinese medical etiology thinks that how smooth by feelings will genus is, depression of liver-QI, and Yu Huahuo of a specified duration, feels malicious heresy again and send out.
Herpes zoster is caused by varicella zoster virus, pathological change is positioned at the neuron of spinal cord posterior root ganglion, when body's immunity is low, cause the varicella zoster virus of hiding in nerve movable again, make the neuroganglion of being invaded and the neurological region of arranging produce inflammatory to change, occur one-sided neuralgia and skin change.Herpes zoster all can be fallen ill throughout the year, with spring and autumn the most common, be apt to occur in middle-aged and elderly people, because this kind of crowd's Abwehrkraft des Koepers declines, insufficiency of vital energy and blood, body repair function is poor, conventional western medicine is responded well to treatment slowly, the course of disease is long, and to neuralgia weak curative effect, gerontal patient often can continue one month or more of a specified duration by post herpetic neuralgia.
The medicine of current treatment herpes zoster is mainly antiviral agents, such as acyclovir, but curative effect is unsatisfactory.
Medical material involved in the present invention is recorded in all as seen " China's book on Chinese herbal medicine ".
Summary of the invention
The present invention aims to provide a kind of medicine being used for the treatment of herpes zoster, by selecting suitable medical material and proportioning thereof, reaches the safe and effective object being applied to herpes zoster.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of medicine being used for the treatment of herpes zoster, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Rhizoma Imperatae 15 parts, the Rhizoma Atractylodis Macrocephalae 9 parts, the Radix Paeoniae Alba 9 parts, Herba Menthae 9 parts, Fericarpium Citri Limoniae 10 parts, Fructus Ligustri Lucidi 6 parts, Herba Lysimachiae 20 parts, Herba hylotelephii erythrosticti 12 parts, Radix Sophorae Flavescentis 9 parts, Melia azedarach L. 6 parts.
Inventor thinks that this cause of disease liver and gall fire is contained, spleen damp-stagnancy is of a specified duration, retention of damp-heat in the interior, is subject to poison evil outward and brings out.Poison evil fire-transformation and liver-fire, damp and hot knot of fighting check meridians, and QI and blood is obstructed, stagnation of QI and blood may bring about pain, therefore disease sees scorching hot pain, scorchingly hot accumulate stagnate in blood system obstructed, then rash move back and pain incessantly.The present invention uses: Herba Lysimachiae removing damp-heat from the liver and the gallbladder; Radix Sophorae Flavescentis, Melia azedarach L. heat clearing and damp drying, killing parasites for relieving itching; The Radix Paeoniae Alba is nourished blood emergency, suppressing the hyperactive liver pain relieving; Be aided with Herba hylotelephii erythrosticti heat-clearing and toxic substances removing; Rhizoma Imperatae clearing away heat and cooling blood; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI; Herba Menthae rash is antipruritic; Fericarpium Citri Limoniae promoting the circulation of QI to relieve pain; Fructus Ligustri Lucidi liver and kidney tonifying, clearind deficient heat; All medicines share, and play effect of eliminating damp-heat, heat-clearing and toxic substances removing, promoting the circulation of QI to relieve pain altogether.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
1, clinical data
Inventor collects Patients with Herpes Zoster 60 example altogether, is traditional Chinese medical science clinic and Dermatology Outpatient Department patient.Man 32 example, female 28 example; The oldest 68 years old, minimum 21 years old; The course of disease is the longest 15 days, the shortest 2 days; Fall ill in head 3 example, cervical region 7 example, breast side of body portion 30 example, back 15 example, lower limb 5 example.
Diagnostic criteria: 1. many in morbidity in season in spring and autumn, common with adult patients.2. before skin lesion occurs, common have skin irritation or burn feeling, can with slight uncomfortable, the heating in the whole body.3. skin lesion mostly is the vesicle of Semen phaseoli radiati size, and bunch integrated group's vesicle appears in bunch integrated group's affected skin, and bleb wall is more nervous, Chang Dancheng zonal distribution, and severe patient skin lesion can show as hemorrhagic or gangraenosum.4. have insufferable pain as seen, or skin lesion disappear take off after still lost pain.
2, Therapeutic Method
All patients takes the decoct that the present invention obtains according to specific embodiment 1, and every bu morning, noon and afternoon take for three times.More after, after treatment gets final product drug withdrawal in 3 days again, the longlyest takes drug withdrawal in 2 weeks.
3, therapeutic outcome
3.1 criterion of therapeutical effect
With reference to " Chinese medical disease Standardization of diagnosis and curative effect " that State Administration of Traditional Chinese Medicine issues.
Cure: deflorescence, clinical sign disappears, without pain sequela.
Take a turn for the better: deflorescence more than 30%, pain obviously alleviates.
Invalid: deflorescence is less than 30%, and pain is without obviously alleviating.
3.2 curative effect
60 examples are all cured, and the course for the treatment of is the shortest 3 days, the longest 10 days, average 7 days.All without post herpetic neuralgia.
3.3 untoward reaction are observed
Period in a medicine has no obvious adverse reaction.
3.4 medical record citings
Grandson so-and-so, female, 53 years old.On December 27th, 2013, plays erythema, vesicle 3 days, sharp ache outside right lateral thigh, so that impact is taken food and sleep, the micro-hardship of companion's mouth, urine yellow skin, large constipation, the micro-Huang of red tongue tongue, stringy pulse.Skin examination is shown in that the erythema, the boundary that have many places to differ in size outside right lateral thigh are clear, and it on, intensive most foxtail millet grain is to the large transparent vesicle of Semen phaseoli radiati, and distribution is as band shape.Tcm diagnosis is that Serpentis alters skin ulcer.Take the decoct that the present invention obtains according to specific embodiment 1, every bu morning, noon and afternoon take for three times.After 2 days, herpes part starts incrustation, and pain is obviously alleviated, and two is just normal, and red tongue with thin fur is white, stringy pulse.Take 2 doses again and heal.Consolidate and take medicine 3 days, have no pain sequela.Follow up a case by regular visits to after 1 year and have no recurrence.
Visible, the medicine that the present invention obtains can safe and effective treatment herpes zoster, has good medical science promotional value.
Detailed description of the invention
In order to understand better and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Take: Rhizoma Imperatae 15 grams, the Rhizoma Atractylodis Macrocephalae 9 grams, the Radix Paeoniae Alba 9 grams, Herba Menthae 9 grams, Fericarpium Citri Limoniae 10 grams, Fructus Ligustri Lucidi 6 grams, Herba Lysimachiae 20 grams, Herba hylotelephii erythrosticti 12 grams, Radix Sophorae Flavescentis 9 grams, Melia azedarach L. 6 grams; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, is concentrated into 120 grams, must meet the decoct of adult normal's one day consumption.
Be used for the treatment of herpes zoster.Oral, every bu morning, noon and afternoon take for three times.
Embodiment 2
Take: Rhizoma Imperatae 15 grams, the Rhizoma Atractylodis Macrocephalae 9 grams, the Radix Paeoniae Alba 9 grams, Herba Menthae 9 grams, Fericarpium Citri Limoniae 10 grams, Fructus Ligustri Lucidi 6 grams, Herba Lysimachiae 20 grams, Herba hylotelephii erythrosticti 12 grams, Radix Sophorae Flavescentis 9 grams, Melia azedarach L. 6 grams; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, dry, packaging, must meet the powder of adult normal's one day consumption.
Be used for the treatment of herpes zoster.Oral, daily once.
Embodiment 3
Take: Rhizoma Imperatae 15 grams, the Rhizoma Atractylodis Macrocephalae 9 grams, the Radix Paeoniae Alba 9 grams, Herba Menthae 9 grams, Fericarpium Citri Limoniae 10 grams, Fructus Ligustri Lucidi 6 grams, Herba Lysimachiae 20 grams, Herba hylotelephii erythrosticti 12 grams, Radix Sophorae Flavescentis 9 grams, Melia azedarach L. 6 grams; Add 6 times of water gagings, decoct 3 times, each decoction 1 hour, merges decoction liquor, concentrated, dry, incapsulates shell, must meet the capsule of adult normal's one day consumption.
Be used for the treatment of herpes zoster.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. one kind is used for the treatment of the medicine of herpes zoster, it is characterized in that, it is prepared from by the raw medicinal material of following weight proportion: Rhizoma Imperatae 15 parts, the Rhizoma Atractylodis Macrocephalae 9 parts, the Radix Paeoniae Alba 9 parts, Herba Menthae 9 parts, Fericarpium Citri Limoniae 10 parts, Fructus Ligustri Lucidi 6 parts, Herba Lysimachiae 20 parts, Herba hylotelephii erythrosticti 12 parts, Radix Sophorae Flavescentis 9 parts, Melia azedarach L. 6 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510306626.XA CN104922512A (en) | 2015-06-05 | 2015-06-05 | Medicine for treating herpes zoster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510306626.XA CN104922512A (en) | 2015-06-05 | 2015-06-05 | Medicine for treating herpes zoster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104922512A true CN104922512A (en) | 2015-09-23 |
Family
ID=54110161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510306626.XA Pending CN104922512A (en) | 2015-06-05 | 2015-06-05 | Medicine for treating herpes zoster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104922512A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07188043A (en) * | 1993-12-28 | 1995-07-25 | Katsuo Nishina | Relieving agent of pain caused by zoster virus |
| CN104547666A (en) * | 2014-12-19 | 2015-04-29 | 辛怡静 | Traditional Chinese medicine composition for treating herpes zoster |
-
2015
- 2015-06-05 CN CN201510306626.XA patent/CN104922512A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07188043A (en) * | 1993-12-28 | 1995-07-25 | Katsuo Nishina | Relieving agent of pain caused by zoster virus |
| CN104547666A (en) * | 2014-12-19 | 2015-04-29 | 辛怡静 | Traditional Chinese medicine composition for treating herpes zoster |
Non-Patent Citations (2)
| Title |
|---|
| 华碧春等: "《袖珍中草药彩色图谱》", 28 February 2002 * |
| 许金华等: "龙胆泻肝汤加减治疗带状疱疹66例", 《内蒙古中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102139030B (en) | Oral Chinese herbal preparation for treating gingivitis and preparation method thereof | |
| CN101773653B (en) | Chinese medicine composition for treating ablepsia and preparation method thereof | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103705782A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103211962B (en) | Chinese medicinal composition for treating anhypnia | |
| CN102657785B (en) | Medicinal composition for treating gingivitis | |
| CN101912548B (en) | Medicament for treating nocturnal fretfulness infants and preparation method thereof | |
| CN103446272A (en) | Composition for improving sleep, and preparation method and use thereof | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN104922512A (en) | Medicine for treating herpes zoster | |
| CN104399042A (en) | Traditional Chinese medicine for treating intractable diaphragmatic muscle spasm and preparation method thereof | |
| CN103142978A (en) | Medicine for treating peripheral facial paralysis | |
| CN103705780A (en) | Medicament for treating intractable insomnia | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN103860914A (en) | Chinese medicine composition for treating epilepsy | |
| CN103550606A (en) | Medicament for treating hypersensitive dentin | |
| CN103638376A (en) | Traditional Chinese medicine tablet for treating rosacea | |
| CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
| CN102657758A (en) | Traditional Chinese medical composition and preparation method and application thereof | |
| CN104771625A (en) | Traditional Chinese medicine for treating migraine | |
| CN104825809A (en) | Medicament for treating peripheral facial paralysis | |
| CN102920945B (en) | Medicinal tea for protecting liver | |
| CN102302734B (en) | Agent for treating insomnia | |
| CN104162038A (en) | Traditional Chinese medicine composition for treating neonatal seizures and preparation method thereof | |
| CN103907933B (en) | Medicated diet for tonifying kidney and supplementing Qi and preparation method of medicated diet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150923 |
|
| WD01 | Invention patent application deemed withdrawn after publication |